Catalent, Novo Nordisk and FTC
Catalent (NYSE:CTLT) is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey to ...
The site also serves as an oral solids development and small-scale manufacturing facility for the pharmaceutical company, ...
On Friday, Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $60.29 which represents a slight increase of $0.20 or 0.33% from the prior close of $60.09. The stock opened at $60 and ...
CTLT announces an agreement to sell its oral solids development and manufacturing facility in Somerset to Ardena.
(Reuters) - Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New ...
Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...
A life sciences company has sold off part of its business that includes a Morrisville facility with hundreds of workers.
J&J beat expectations this week to launch the Q3 earnings season; a study about children treated with bluebird bio’s Skysona ...